These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study. Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765 [TBL] [Abstract][Full Text] [Related]
16. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up. Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868 [TBL] [Abstract][Full Text] [Related]
17. Wasting and body changes: what do we know so far? Gomez E Newsline People AIDS Coalit N Y; 1998 Sep; ():34-6. PubMed ID: 11367489 [TBL] [Abstract][Full Text] [Related]
18. Body composition changes with protease therapy. Berger D Posit Aware; 1998; 9(5):47. PubMed ID: 11365895 [TBL] [Abstract][Full Text] [Related]
19. Metabolic problems and PIs. Treat Rev; 1997 Nov; (No 26-27):13. PubMed ID: 11364932 [TBL] [Abstract][Full Text] [Related]
20. Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy. Terry L; Sprinz E; Stein R; Medeiros NB; Oliveira J; Ribeiro JP Med Sci Sports Exerc; 2006 Mar; 38(3):411-7. PubMed ID: 16540826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]